Detecting ovarian cancer using blood tests and imaging techniques
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
This study is looking for better ways to spot ovarian cancer early by finding specific markers in the blood and using advanced imaging techniques, so women at high risk can get important information to help them make smart health choices before the cancer spreads.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11008916 on NIH RePORTER |
What this research studies
This research focuses on improving the early detection of ovarian cancer, which is often diagnosed too late for effective treatment. It aims to identify specific blood-based biomarkers and imaging techniques that can reveal precancerous changes in women at high risk for ovarian cancer. By analyzing serum protein changes and utilizing advanced imaging methods, the study seeks to develop a minimally invasive test that can detect ovarian high-grade serous carcinoma before it spreads. This could provide women with critical information to make informed decisions about their health and treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are women at high risk for ovarian cancer who are considering delaying or avoiding risk-reducing salpingo-oophorectomy.
Not a fit: Patients who do not have a high risk for ovarian cancer or those who are already diagnosed with advanced ovarian cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of ovarian cancer, significantly improving survival rates and treatment outcomes for patients.
How similar studies have performed: Other research has shown promise in using biomarkers and imaging for early cancer detection, suggesting that this approach could be effective.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Barton, Jennifer Kehlet — University of Arizona
- Study coordinator: Barton, Jennifer Kehlet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.